Literature DB >> 15823182

Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis.

P M C Pitrez1, S Brennan, S Turner, P D Sly.   

Abstract

OBJECTIVE: The aim of this study was to determine whether nasal inflammation reflects pulmonary inflammation in young children with cystic fibrosis (CF), as assessed by inflammatory markers in nasal wash (NW) and bronchoalveolar lavage (BAL), respectively.
METHODS: CF patients younger than 6 years of age who were to undergo bronchoscopy for routine BAL from May 2000 to October 2001 were recruited for this study. NW was collected immediately after the patient was sedated for bronchoscopy. Total cell counts (TCC), differential cell counts and interleukin (IL)-8 levels (enzyme-linked immunosorbent assay) were assessed in NW and BAL.
RESULTS: In total, 19 children with CF (mean age, 1.9 years; SD, 1.7 years) were included in the study. There was a significant relationship between IL-8 and the percentages of neutrophils in NW (r (2) = 0.76; P < 0.001) and in BAL fluid (r 2 = 0.62; P = 0.006). Similarly, IL-8 concentrations in the NW correlated with those in the BAL (r 2 = 0.48; P = 0.036) and neutrophil percentages in NW correlated significantly with those in BAL (r 2 = 0.7; P = 0.004).
CONCLUSION: When measured under 'ideal' conditions, nasal IL-8 reflects lower airway levels and may reflect the inflammatory stimulus that results in neutrophilic inflammation. These data encourage further assessment of nasal wash under clinically appropriate conditions to determine its utility for assessing inflammation in young children with CF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823182     DOI: 10.1111/j.1440-1843.2005.00649.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  9 in total

1.  Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation.

Authors:  Chang Keun Kim; Zak Callaway; Young Yull Koh; Soo-Hee Kim; Takao Fujisawa
Journal:  Lung       Date:  2011-12-13       Impact factor: 2.584

2.  Overcoming heterogeneity in pediatric asthma: tobacco smoke and asthma characteristics within phenotypic clusters in an African American cohort.

Authors:  Angela S Benton; Zuyi Wang; Jennifer Lerner; Matthew Foerster; Stephen J Teach; Robert J Freishtat
Journal:  J Asthma       Date:  2010-09       Impact factor: 2.515

3.  Airway platelet activation is associated with airway eosinophilic inflammation in asthma.

Authors:  Angela S Benton; Nikila Kumar; Jennifer Lerner; Andrew A Wiles; Matthew Foerster; Stephen J Teach; Robert J Freishtat
Journal:  J Investig Med       Date:  2010-12       Impact factor: 2.895

Review 4.  A review of the application of inflammatory biomarkers in epidemiologic cancer research.

Authors:  Darren R Brenner; Dominique Scherer; Kenneth Muir; Joellen Schildkraut; Paolo Boffetta; Margaret R Spitz; Loic Le Marchand; Andrew T Chan; Ellen L Goode; Cornelia M Ulrich; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254

5.  Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies.

Authors:  Catherine M McDougall; Morgan G Blaylock; J Graham Douglas; Richard J Brooker; Peter J Helms; Garry M Walsh
Journal:  Am J Respir Cell Mol Biol       Date:  2008-05-15       Impact factor: 6.914

6.  Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19.

Authors:  Tanja Gangnus; Bjoern B Burckhardt
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

7.  IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations.

Authors:  George M Solomon; Carla Frederick; Shaoyan Zhang; Amit Gaggar; Tom Harris; Bradford A Woodworth; Chad Steele; Steven M Rowe
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

8.  Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.

Authors:  Ruth K Michl; Julia Hentschel; Christiane Fischer; James F Beck; Jochen G Mainz
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

9.  Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.

Authors:  Julia Hentschel; Manuela Jäger; Natalie Beiersdorf; Nele Fischer; Franziska Doht; Ruth K Michl; Thomas Lehmann; Udo R Markert; Klas Böer; Peter M Keller; Mathias W Pletz; Jochen G Mainz
Journal:  BMC Pulm Med       Date:  2014-05-13       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.